In vitro keratinocyte antiproliferant effect of Centella asiatica extract and triterpenoid saponins

J. H. Sampson, Amala Soumyanath, G. Karlsen, H. Navsaria, I. M M O P Leigh

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Psoriasis is a hyperproliferative skin disorder estimated to be present in 1-3 % of most populations. Conventional therapy using corticosteroids, Vitamin D analogs and cytotoxic agents eg psoralens is associated with low success rate and many side effects. Traditional plant remedies may provide leads for new treatments. A rapid-throughput, in vitro bioassay has been utilised to examine plants for inhibitory effects on the growth of SVK-14 keratinocytes. Centella asiatica, a reputed anti-psoriatic herb, has been compared against the psoralen-containing seeds of Psoralea corylifolia and the synthetic anti-psoriatic agent dithranol (anthralin). Aqueous extracts of Psoralea corylifolia and Centella asiatica inhibited keratinocyte replication with IC50 values of 18.4 ± 0.6 μg/ml and 209.9 ± 9.8 mg/ml respectively prior to treatment with polyvinyipolypyrrolidone (PVPP) and 36.3 ± 3.3 mg/ml and 238.0 ± 2.5 mg/ml respectively after PVPP treatment of the extracts. The effect produced by C. asiatica is thus unlikely to be due to phenolic compounds. It may, however, be due to its two consitituent triterpenoid glycosides madecassoside and asiaticoside which had IC50 values of 8.6 ± 0.1 μM and 8.4 ± 0.6 μM respectively. These values were comparable to their concentrations in the crude extract and to the IC50 of dithranol (5.2 ± 0.4 μM). These results suggest that the potential use of C. asiatica extracts as a topical anti-psoriatic agent is worthy of further investigation.

Original languageEnglish (US)
Pages (from-to)230-235
Number of pages6
JournalPhytomedicine
Volume8
Issue number3
StatePublished - 2001
Externally publishedYes

Fingerprint

Centella
Anthralin
Centella asiatica
triterpenoid saponins
keratinocytes
Saponins
Psoralea
Keratinocytes
Inhibitory Concentration 50
Cullen corylifolium
inhibitory concentration 50
extracts
Ficusin
Bioassay
Cytotoxins
Glycosides
psoralen
psoriasis
Complex Mixtures
Psoriasis

Keywords

  • Centella asiatica
  • Dithranol
  • Keratinocytes
  • Psoralea corylifolia
  • Psoriasis
  • SVK-14

ASJC Scopus subject areas

  • Plant Science
  • Drug Discovery
  • Organic Chemistry
  • Pharmacology

Cite this

Sampson, J. H., Soumyanath, A., Karlsen, G., Navsaria, H., & Leigh, I. M. M. O. P. (2001). In vitro keratinocyte antiproliferant effect of Centella asiatica extract and triterpenoid saponins. Phytomedicine, 8(3), 230-235.

In vitro keratinocyte antiproliferant effect of Centella asiatica extract and triterpenoid saponins. / Sampson, J. H.; Soumyanath, Amala; Karlsen, G.; Navsaria, H.; Leigh, I. M M O P.

In: Phytomedicine, Vol. 8, No. 3, 2001, p. 230-235.

Research output: Contribution to journalArticle

Sampson, JH, Soumyanath, A, Karlsen, G, Navsaria, H & Leigh, IMMOP 2001, 'In vitro keratinocyte antiproliferant effect of Centella asiatica extract and triterpenoid saponins', Phytomedicine, vol. 8, no. 3, pp. 230-235.
Sampson, J. H. ; Soumyanath, Amala ; Karlsen, G. ; Navsaria, H. ; Leigh, I. M M O P. / In vitro keratinocyte antiproliferant effect of Centella asiatica extract and triterpenoid saponins. In: Phytomedicine. 2001 ; Vol. 8, No. 3. pp. 230-235.
@article{6d4f6717435349359530071b4cddd263,
title = "In vitro keratinocyte antiproliferant effect of Centella asiatica extract and triterpenoid saponins",
abstract = "Psoriasis is a hyperproliferative skin disorder estimated to be present in 1-3 {\%} of most populations. Conventional therapy using corticosteroids, Vitamin D analogs and cytotoxic agents eg psoralens is associated with low success rate and many side effects. Traditional plant remedies may provide leads for new treatments. A rapid-throughput, in vitro bioassay has been utilised to examine plants for inhibitory effects on the growth of SVK-14 keratinocytes. Centella asiatica, a reputed anti-psoriatic herb, has been compared against the psoralen-containing seeds of Psoralea corylifolia and the synthetic anti-psoriatic agent dithranol (anthralin). Aqueous extracts of Psoralea corylifolia and Centella asiatica inhibited keratinocyte replication with IC50 values of 18.4 ± 0.6 μg/ml and 209.9 ± 9.8 mg/ml respectively prior to treatment with polyvinyipolypyrrolidone (PVPP) and 36.3 ± 3.3 mg/ml and 238.0 ± 2.5 mg/ml respectively after PVPP treatment of the extracts. The effect produced by C. asiatica is thus unlikely to be due to phenolic compounds. It may, however, be due to its two consitituent triterpenoid glycosides madecassoside and asiaticoside which had IC50 values of 8.6 ± 0.1 μM and 8.4 ± 0.6 μM respectively. These values were comparable to their concentrations in the crude extract and to the IC50 of dithranol (5.2 ± 0.4 μM). These results suggest that the potential use of C. asiatica extracts as a topical anti-psoriatic agent is worthy of further investigation.",
keywords = "Centella asiatica, Dithranol, Keratinocytes, Psoralea corylifolia, Psoriasis, SVK-14",
author = "Sampson, {J. H.} and Amala Soumyanath and G. Karlsen and H. Navsaria and Leigh, {I. M M O P}",
year = "2001",
language = "English (US)",
volume = "8",
pages = "230--235",
journal = "Phytomedicine",
issn = "0944-7113",
publisher = "Urban und Fischer Verlag Jena",
number = "3",

}

TY - JOUR

T1 - In vitro keratinocyte antiproliferant effect of Centella asiatica extract and triterpenoid saponins

AU - Sampson, J. H.

AU - Soumyanath, Amala

AU - Karlsen, G.

AU - Navsaria, H.

AU - Leigh, I. M M O P

PY - 2001

Y1 - 2001

N2 - Psoriasis is a hyperproliferative skin disorder estimated to be present in 1-3 % of most populations. Conventional therapy using corticosteroids, Vitamin D analogs and cytotoxic agents eg psoralens is associated with low success rate and many side effects. Traditional plant remedies may provide leads for new treatments. A rapid-throughput, in vitro bioassay has been utilised to examine plants for inhibitory effects on the growth of SVK-14 keratinocytes. Centella asiatica, a reputed anti-psoriatic herb, has been compared against the psoralen-containing seeds of Psoralea corylifolia and the synthetic anti-psoriatic agent dithranol (anthralin). Aqueous extracts of Psoralea corylifolia and Centella asiatica inhibited keratinocyte replication with IC50 values of 18.4 ± 0.6 μg/ml and 209.9 ± 9.8 mg/ml respectively prior to treatment with polyvinyipolypyrrolidone (PVPP) and 36.3 ± 3.3 mg/ml and 238.0 ± 2.5 mg/ml respectively after PVPP treatment of the extracts. The effect produced by C. asiatica is thus unlikely to be due to phenolic compounds. It may, however, be due to its two consitituent triterpenoid glycosides madecassoside and asiaticoside which had IC50 values of 8.6 ± 0.1 μM and 8.4 ± 0.6 μM respectively. These values were comparable to their concentrations in the crude extract and to the IC50 of dithranol (5.2 ± 0.4 μM). These results suggest that the potential use of C. asiatica extracts as a topical anti-psoriatic agent is worthy of further investigation.

AB - Psoriasis is a hyperproliferative skin disorder estimated to be present in 1-3 % of most populations. Conventional therapy using corticosteroids, Vitamin D analogs and cytotoxic agents eg psoralens is associated with low success rate and many side effects. Traditional plant remedies may provide leads for new treatments. A rapid-throughput, in vitro bioassay has been utilised to examine plants for inhibitory effects on the growth of SVK-14 keratinocytes. Centella asiatica, a reputed anti-psoriatic herb, has been compared against the psoralen-containing seeds of Psoralea corylifolia and the synthetic anti-psoriatic agent dithranol (anthralin). Aqueous extracts of Psoralea corylifolia and Centella asiatica inhibited keratinocyte replication with IC50 values of 18.4 ± 0.6 μg/ml and 209.9 ± 9.8 mg/ml respectively prior to treatment with polyvinyipolypyrrolidone (PVPP) and 36.3 ± 3.3 mg/ml and 238.0 ± 2.5 mg/ml respectively after PVPP treatment of the extracts. The effect produced by C. asiatica is thus unlikely to be due to phenolic compounds. It may, however, be due to its two consitituent triterpenoid glycosides madecassoside and asiaticoside which had IC50 values of 8.6 ± 0.1 μM and 8.4 ± 0.6 μM respectively. These values were comparable to their concentrations in the crude extract and to the IC50 of dithranol (5.2 ± 0.4 μM). These results suggest that the potential use of C. asiatica extracts as a topical anti-psoriatic agent is worthy of further investigation.

KW - Centella asiatica

KW - Dithranol

KW - Keratinocytes

KW - Psoralea corylifolia

KW - Psoriasis

KW - SVK-14

UR - http://www.scopus.com/inward/record.url?scp=0034993034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034993034&partnerID=8YFLogxK

M3 - Article

C2 - 11417919

AN - SCOPUS:0034993034

VL - 8

SP - 230

EP - 235

JO - Phytomedicine

JF - Phytomedicine

SN - 0944-7113

IS - 3

ER -